# MIFEPRISTONE
> **ANDA216616** · Abbreviated New Drug Application (Generic) · Sponsor: EVITA SOLUTIONS · Approved 2025-09-30
## Drug
- **FDA Application Number:** ANDA216616
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIFEPRISTONE
- **Generic name:** MIFEPRISTONE
- **Active ingredients:** MIFEPRISTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EVITA SOLUTIONS
- **Manufacturer:** Evita Solutions LLC
- **First approval:** 2025-09-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216616)
---
*MORVS · CC0 1.0*